Additionally, the 6 markers (KDR, CXCR6, STAT5A, MPL, NFATC3, and TLR6) we found to be downregulated in our late-recurring tumor samples are also biologically relevant to functional T-cell activity, which helps explain their expression and function in this context. This evidence concerns the gene TLR6 and neoplasm.